Loading
Janna Goldfeld, PA-C
Janna Goldfeld, PA-C
Janna Goldfeld, PA-C, is a nationally board-certified Physician Assistant with more than 20 years of experience in family medicine, internal medicine, ENT, general surgery, and bariatric/weight loss care.

Biography





🔹 Florida Surgery & Weight Loss Center – Present

  • Provides personalized weight loss care, bariatric surgery coordination, and comprehensive primary care
  • Manages obesity, diabetes, hypertension, high cholesterol, and other chronic conditions
  • Sees patients for wellness visits, physicals, and ongoing medical support
  • Delivered internal medicine and senior care services
  • Oversaw chronic disease management, diagnostics, and wellness exams
  • Treated adult and geriatric patients in a family medicine setting
  • Collaborated with cardiology, endocrinology, gastroenterology, and other specialists

Or Book Online to schedule your consultation.


Certificates
Our Certificates

We are proud members of ASMSB. Being a member of the ASMSB provides our board-certified medical staff and surgeons with access to the best resources, information, and support to advance the science of metabolic and bariatric surgery.

Recent News

Health Blog

Our health blogs provide patients with great tips about weight loss and a healthy lifestyle within your reach.

View All Blogs
Can You Stop Tesamorelin Suddenly? A Physician Explains

Learn whether you can stop Tesamorelin suddenly or if tapering is recommended. Physician-reviewed guide covering what happens after stopping, restarting Tesamorelin, belly fat changes, treatment duration, and common patient questions.

Discover More
Can Tesamorelin Help Reduce Belly Fat? Understanding Dosage, Treatment Plans & What to Expect

Learn how healthcare providers determine Tesamorelin dosage for belly fat, what affects treatment plans, and why there is no one-size-fits-all approach. Explore physician-guided care, body composition, visceral fat, and use our Tesamorelin dosage calculator to estimate dose, units, mL, and reconstitution.

Discover More
Medicare GLP-1 Bridge Program Explained: Wegovy®, Zepbound® & Weight Loss Coverage Starting July 2026

The Medicare GLP-1 Bridge Program launches July 1, 2026, giving eligible Medicare beneficiaries access to covered weight loss medications including Wegovy®, Foundayo®, and Zepbound® KwikPen®. Patients who qualify may receive treatment with a fixed $50 copay after provider review and prior authorization approval. Learn who qualifies, which medications are covered, and how to apply.

Discover More
Skip to content